Spots Global Cancer Trial Database for intermediate 1 risk mds
Every month we try and update this database with for intermediate 1 risk mds cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS | NCT03573310 | Neoplasms Solid Tumor, Ad... Non-Hodgkin Lym... Myelodysplastic... | JNJ-64619178 | 18 Years - | Janssen Research & Development, LLC |